The Associations of Iron Related Biomarkers with Risk, Clinical Severity and Mortality in SARS-CoV-2 Patients: A Meta-Analysis

The coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is spreading rapidly around the world and has led to millions of infections and deaths. Growing evidence indicates that iron metabolism is associated with COVID-19 progression, and iron-related biomarkers have great potential for detecting these diseases. However, the results of previous studies are conflicting, and there is not consistent numerical magnitude relationship between those biomarkers and COVID-19. Thereby, we aimed to integrate the results of current studies and to further explore their relationships through a meta-analysis. We searched peer-reviewed literature in PubMed, Scopus and Web of Science up to 31 May 2022. A random effects model was used for pooling standard mean difference (SMD) and the calculation of the corresponding 95% confidence interval (CI). I-2 was used to evaluate heterogeneity among studies. A total of 72 eligible articles were included in the meta-analysis. It was found that the ferritin levels of patients increased with the severity of the disease, whereas their serum iron levels and hemoglobin levels showed opposite trends. In addition, non-survivors had higher ferritin levels (SMD (95%CI): 1.121 (0.854, 1.388); Z = 8.22 p for Z < 0.001; I-2 = 95.7%, p for I-2 < 0.001), lower serum iron levels (SMD (95%CI): -0.483 (-0.597, -0.368), Z = 8.27, p for Z < 0.001; I-2 = 0.9%, p for I-2 =0.423) and significantly lower TIBC levels (SMD (95%CI): -0.612 (-0.900, -0.324), Z = 4.16, p for Z < 0.001; I-2 = 71%, p for I-2 = 0.016) than survivors. This meta-analysis demonstrates that ferritin, serum iron, hemoglobin and total iron banding capacity (TIBC) levels are strongly associated with the risk, severity and mortality of COVID-19, providing strong evidence for their potential in predicting disease occurrence and progression.

Automated summary

This study conducted a meta-analysis and found that ferritin, serum iron, hemoglobin, and total iron binding capacity (TIBC) levels are strongly associated with the risk, severity, and mortality of COVID-19. Non-survivors have higher ferritin levels and lower serum iron and TIBC levels compared to survivors.